Healthcare sector

  • 文章类型: Journal Article
    本文旨在回顾阿拉伯联合酋长国(UAE)的医疗保健系统以及国际认证的利用,以提高医疗保健服务质量并发展其医疗旅游业。医疗旅游为阿联酋的经济做出了贡献。因此,该国授权公共和私营设施的国际认证,以吸引患者并促进医疗旅游。认证是全球公认的实施质量和患者安全标准的主要驱动因素之一。这引起了人们对研究此类评估的影响和结果的极大兴趣。因此,本文的第二个目的是回顾阿联酋利用国际认证提高医疗服务质量的战略目标.尽管努力实现全球认证吸引了游客,必须了解此类评估的需求和结果。这篇评论显示了阿联酋医疗保健部门如何通过认证来提高其医疗保健服务质量。在提高此类服务的质量和增加医疗旅游业的同时,为外籍人士移居阿联酋提供了许多机会,该国应致力于通过扩展到其他中东国家来加强其医疗服务。本文可能会影响在阿联酋和中东地区实施国际认证的政策制定者。
    This paper aims to review the healthcare system in the United Arab Emirates (UAE) and the utilisation of international accreditation to improve the quality of healthcare services and to grow its medical tourism industry. Medical tourism has contributed to the UAE\'s economy. Hence, the country mandated international accreditation in public and private facilities to attract patients and boost medical tourism. Accreditation is recognised worldwide as one of the main drivers for implementing quality and patient safety standards, which has sparked considerable interest in studying the effects and outcomes of such assessments. Therefore, the second aim of this paper is to review the UAE\'s strategic goals to improve the quality of healthcare services using international accreditation. Although striving to achieve global accreditation attracts tourists, it is essential to understand the needs and outcomes of such assessments. This review showed how the UAE healthcare sector has evolved to improve the quality of its healthcare services through accreditation. While enhancing the quality of such services and increasing the medical tourism industry provided many opportunities for expatriates to move to the UAE, the country should aim to strengthen its medical services by expanding to other Middle Eastern countries. This paper could influence policymakers implementing international accreditation in the UAE and the Middle Eastern region.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    仆人式领导作为一种可行的领导模式,能够在日益复杂的医疗保健系统中带来积极的变化,在学者和从业者中得到了越来越多的考虑。医疗保健中越来越多的仆人式领导文献需要进行综合研究工作,以提供现有研究的整体情况。这篇系统的综述旨在综合仆人式领导的概念化,理论框架,测量工具,和法理网络(前身,调解员,结果,和主持人)与先前的医疗保健研究相关。对55项相关的医疗保健特定概念和实证研究的系统综合表明,仆人式领导在培养致力于实现医疗保健卓越绩效的员工队伍方面发挥着至关重要的作用。审查发现,全球仆人领导能力量表是医疗保健行业特定研究中最常用的仆人领导能力指标。此外,社会交换理论是解释仆人式领导对特定利益变量影响的主导支撑机制。研究结果进一步表明,仆人式领导与医疗保健中一系列有价值的个人和组织成果有着积极的关系。我们的审查有助于公务员领导理论和实践的发展,通过确定特定部门的研究在医疗保健领域。最后,我们通过提供一个详细的全景为未来的医疗保健特定的仆人领导研究在潜在的主题方面,方法的严谨,在先前的研究中,较少探索变量。
    Servant leadership has received a growing consideration among scholars and practitioners as a viable leadership model capable of bringing positive changes in the increasingly complex healthcare system. The increasing servant leadership literature in healthcare requires an integrated research work that provides a holistic picture of the existing studies. This systematic review aims to synthesize servant leadership conceptualizations, theoretical frameworks, measurement tools, and nomological networks (antecedents, mediators, outcomes, and moderators) associated with prior research in healthcare. A systematic synthesis of 55 pertinent healthcare-specific conceptual and empirical studies demonstrated that servant leadership assumes a crucial role in developing a committed workforce that contributes towards the achievement of performance excellence in healthcare. The review uncovers that the Global Servant Leadership Scale is the most utilized measure of servant leadership in sector-specific studies in healthcare. Moreover, social exchange theory is the dominant underpinning mechanism explaining the influence of servant leadership on specific variables of interest. The findings further revealed that servant leadership has a positive relationship with a range of valued individual and organizational outcomes in healthcare. Our review contributes to the development of servant leadership theory and practice through ascertaining sector-specific studies in the territory of healthcare. We finally conclude by providing a detailed panorama for future healthcare-specific servant leadership research in terms of potential topics, methodological rigor, and less explored variables in prior studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Review
    目的:已经对防御医学进行了几项研究,但是从管理角度进行的研究仍然很少。因此,本研究的目的是进行文献综述,从管理的角度更好地理解防御医学。
    方法:针对医疗保健提供者的组织(中观)水平和管理实践进行了文献综述。处理了28项研究的最终样本。
    结果:防御医学主要在美国进行研究,学者主要使用定量调查。高风险专业一直是一个关键的调查领域,大部分论文发表在涵盖医学的期刊上,卫生政策,教育和法律领域。分析表明,运营和人员配置是讨论最多的管理实践。没有研究考虑规划和预算方面。
    结论:审查证实,防御性医学的管理方面尚未得到充分解决。受到这种差距的刺激,这项研究分析了防御性医学现象的管理背景,并显示了分析最多的管理实践。本文还有助于从管理方面发展防御性医学的文献。未来研究的领域包括定性研究,以调查医疗保健公司经理的行为,从而对防御性医学和组织的决策提出不同的看法。
    结论:由于仅选择了两个数据库,因此这项工作可能错过了一些重要的出版物。可以通过使用英语作为纳入标准来施加进一步的限制。
    OBJECTIVE: Several studies have been carried out on defensive medicine, but research from the managerial viewpoint is still scarce. Therefore, the aim of the present study is to conduct a literature review to better understand defensive medicine from a managerial perspective.
    METHODS: A literature review was conducted of studies focusing on the organisational (meso) level of healthcare providers and managerial practices. A final sample of 28 studies was processed.
    RESULTS: Defensive medicine has mainly been studied in the USA, and scholars have principally used quantitative surveys. High-risk specialities have been a critical field of investigation, and a large portion of the papers are published in journals that cover medicine, health policy, education and law fields. The analysis showed that operations and the organisation of staffing were the most discussed managerial practices. No study considered planning and budgeting aspects.
    CONCLUSIONS: The review confirmed that the managerial aspect of defensive medicine has not been fully addressed. Stimulated by this gap, this study analyses the managerial background of the defensive medicine phenomenon and shows which managerial practices have been most analysed. This paper also contributes to developing the literature on defensive medicine from the managerial side. Areas for future research include qualitative studies to investigate the behaviour of managers of healthcare companies to give a different perspective on defensive medicine and organisations\' decision-making.
    CONCLUSIONS: Some important publications might have been missed in this work because of the choice of only two databases. A further limit could be imposed by the use of the English language as an inclusion criterion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:COVID-19大流行对长期护理机构(LTCF)的影响最大,它不成比例地伤害了老年人,加剧了社会孤立和孤独感(SIL)。与他人近距离生活,需要全天候协助,与老年人的互动,以前是当面的,已被使用信息和通信技术(ICT)的虚拟聊天所取代。ICT应用,如FaceTime,缩放,和微软团队的视频聊天已被家庭压倒性地用于维持居民的社会资本,并随后减少他们的SIL。
    目的:由于缺乏对这种日益增长的社会交往形式的实质性知识,本系统评价旨在综合COVID-19期间ICT干预措施对LTCF居民SIL的影响.
    方法:我们将包括中文发表的研究,英语,和法语从2019年12月起。除了传统的搜索策略方法之外,要查询的12个电子数据库中有4个是中文。我们将包括定量和干预研究以及定性和混合方法设计。使用2人的方法,主要研究者和一位作者将盲目筛选合格的文章,提取数据,并评估偏见的风险。为了提高第一轮筛选,将使用经过试点测试的算法。分歧将通过与第三作者的讨论来解决。结果将作为纳入研究的结构化摘要呈现。如果有足够的数据,我们计划进行荟萃分析。
    结果:迄今为止,共检索到1803篇文章。中国数据库的查询正在进行中。系统审查和后续手稿将于2022年秋季完成。
    结论:通过提供一种维持LTCF居民与其家人之间沟通的方式,ICT应用已成为减少SIL的有希望的途径,并且肯定会保持在COVID-19后时期。这篇评论将调查和描述与上下文相关的高质量计划和倡议,在宏观层面,政策制定者和研究人员,一线经理,和家庭。这些方法在后COVID-19时代仍将适用。
    未经批准:DERR1-10.2196/36269。
    BACKGROUND: The COVID-19 pandemic has had the greatest impact in long-term care facilities (LTCFs) by disproportionately harming older adults and heightening social isolation and loneliness (SIL). Living in close quarters with others and in need of around-the-clock assistance, interactions with older adults, which were previously in person, have been replaced by virtual chatting using information and communication technologies (ICTs). ICT applications such as FaceTime, Zoom, and Microsoft Teams video chatting have been overwhelmingly used by families to maintain residents\' social capital and subsequently reduce their SIL.
    OBJECTIVE: Because of the lack of substantive knowledge on this ever-increasing form of social communication, this systematic review intends to synthesize the effects of ICT interventions to address SIL among residents in LTCFs during the COVID-19 period.
    METHODS: We will include studies published in Chinese, English, and French from December 2019 onwards. Beyond the traditional search strategy approach, 4 of the 12 electronic databases to be queried will be in Chinese. We will include quantitative and intervention studies as well as qualitative and mixed methods designs. Using a 2-person approach, the principal investigator and one author will blindly screen eligible articles, extract data, and assess risk of bias. In order to improve the first round of screening, a pilot-tested algorithm will be used. Disagreements will be resolved through discussion with a third author. Results will be presented as structured summaries of the included studies. We plan to conduct a meta-analysis if sufficient data are available.
    RESULTS: A total of 1803 articles have been retrieved to date. Queries of the Chinese databases are ongoing. The systematic review and subsequent manuscript will be completed by the fall of 2022.
    CONCLUSIONS: ICT applications have become a promising avenue to reduce SIL by providing a way to maintain communication between LTCF residents and their families and will certainly remain in the post-COVID-19 period. This review will investigate and describe context-pertinent and high-quality programs and initiatives to inform, at the macro level, policy makers and researchers, frontline managers, and families. These methods will remain relevant in the post-COVID-19 era.
    UNASSIGNED: DERR1-10.2196/36269.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    寻求新型药物递送载体的开发以增强标准药物的治疗有效性。迫切需要设计可持续的新型药物输送工具,生物相容性具有最小化的细胞毒性,无免疫原性,高稳定性,循环时间长,并且能够避免免疫系统的识别。在这种对理想的候选药物输送车辆的追求,两性离子材料已经实现了几乎所有这些期望。这篇全面的综述介绍了两性离子聚合物结构作为前瞻性可持续药物递送载体所取得的进展。具有不同结构的两性离子聚合物,如附加蛋白质缀合物,纳米粒子,表面涂层,脂质体,水凝胶,etc,本文对用于制造药物输送载体的方法进行了综述。简要介绍了两性离子聚合物及其作为可靠药物递送载体的应用,如两性离子聚合物-蛋白质缀合物,基于两性离子聚合物的药物纳米载体,本文讨论了刺激响应性两性离子聚合物。两性离子结构显示的前景表明了它们在该领域的巨大潜力。这项重要的审查将鼓励在这一领域工作的研究人员,并促进此类设备的开发和商业化,以使医疗保健协会受益。
    Developments of novel drug delivery vehicles are sought-after to augment the therapeutic effectiveness of standard drugs. An urgency to design novel drug delivery vehicles that are sustainable, biocompatible, have minimized cytotoxicity, no immunogenicity, high stability, long circulation time, and are capable of averting recognition by the immune system is perceived. In this pursuit for an ideal candidate for drug delivery vehicles, zwitterionic materials have come up as fulfilling almost all these expectations. This comprehensive review is presenting the progress made by zwitterionic polymeric architectures as prospective sustainable drug delivery vehicles. Zwitterionic polymers with varied architecture such as appending protein conjugates, nanoparticles, surface coatings, liposomes, hydrogels, etc, used to fabricate drug delivery vehicles are reviewed here. A brief introduction of zwitterionic polymers and their application as reliable drug delivery vehicles, such as zwitterionic polymer-protein conjugates, zwitterionic polymer-based drug nanocarriers, and stimulus-responsive zwitterionic polymers are discussed in this discourse. The prospects shown by zwitterionic architecture suggest the tremendous potential for them in this domain. This critical review will encourage the researchers working in this area and boost the development and commercialization of such devices to benefit the healthcare fraternity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    高质量的研究对于指导循证护理至关重要,并且应该以可重复的方式报告,透明,在适当的情况下,为纳入未来的荟萃分析提供足够的细节。各种研究设计的报告指南已广泛用于临床(和临床前)研究,由包含最小点集的清单组成。随着最近使用人工智能(AI)的研究数量的增加,需要评估其他因素,不完全符合传统的报告准则(例如,与技术算法开发相关的详细信息)。在这次审查中,强调报告指南,以提高对评估医疗保健中AI干预研究所需的基本内容的认识。其中包括已发布和正在进行的对众所周知的报告指南的扩展,例如标准协议项目:对介入试验的建议-AI(研究协议),报告试验综合标准-AI(随机对照试验),诊断准确性研究报告标准-AI(诊断准确性研究)和个人预后或诊断多变量预测模型的透明报告-AI(预测模型研究)。此外,还有许多指南更广泛地考虑将人工智能用于健康干预(例如,医学影像人工智能清单(CLAIM),最小信息(MI)-索赔,用于医疗AI报告的MI)或解决特定元素,例如“学习曲线”(决策AI的发展和探索性临床研究)。人工智能健康干预措施的经济评估目前尚未解决,并可能受益于现有准则的扩展。面对AI健康干预研究的迅速涌入,报告指南有助于确保研究人员和评估研究人员同时考虑良好研究设计和报告的公认要素,同时也充分应对AI特定元素带来的新挑战。
    High-quality research is essential in guiding evidence-based care, and should be reported in a way that is reproducible, transparent and where appropriate, provide sufficient detail for inclusion in future meta-analyses. Reporting guidelines for various study designs have been widely used for clinical (and preclinical) studies, consisting of checklists with a minimum set of points for inclusion. With the recent rise in volume of research using artificial intelligence (AI), additional factors need to be evaluated, which do not neatly conform to traditional reporting guidelines (eg, details relating to technical algorithm development). In this review, reporting guidelines are highlighted to promote awareness of essential content required for studies evaluating AI interventions in healthcare. These include published and in progress extensions to well-known reporting guidelines such as Standard Protocol Items: Recommendations for Interventional Trials-AI (study protocols), Consolidated Standards of Reporting Trials-AI (randomised controlled trials), Standards for Reporting of Diagnostic Accuracy Studies-AI (diagnostic accuracy studies) and Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis-AI (prediction model studies). Additionally there are a number of guidelines that consider AI for health interventions more generally (eg, Checklist for Artificial Intelligence in Medical Imaging (CLAIM), minimum information (MI)-CLAIM, MI for Medical AI Reporting) or address a specific element such as the \'learning curve\' (Developmental and Exploratory Clinical Investigation of Decision-AI) . Economic evaluation of AI health interventions is not currently addressed, and may benefit from extension to an existing guideline. In the face of a rapid influx of studies of AI health interventions, reporting guidelines help ensure that investigators and those appraising studies consider both the well-recognised elements of good study design and reporting, while also adequately addressing new challenges posed by AI-specific elements.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号